US Map / Florida
State FL

Clinical Trials in Florida

Florida is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Florida and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 609 actively recruiting studies with Florida sites out of 609 registered in total. The busiest research areas in Florida are Heart Failure, Prostate Cancer, Alzheimer Disease. Leading sponsors running trials in the state include University of Florida, Mayo Clinic, University of Miami. By stage, Florida trials break down as Phase 1 (119), Phase 2 (174), Phase 3 (129), Phase 4 (19).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
609
Recruiting Now
609
← Back to US Map
Top Conditions in Florida
Heart Failure (9)Prostate Cancer (8)Alzheimer Disease (7)Dementia (6)Breast Cancer (6)Advanced Solid Tumor (6)Metastatic Breast Cancer (6)Non-Small Cell Lung Cancer (6)Ulcerative Colitis (6)Acute Myeloid Leukemia (6)Stroke (5)Myelodysplastic Syndromes (5)

Frequently Asked Questions — Clinical Trials in Florida

How many clinical trials are currently recruiting in Florida?
ClinicalMetric currently tracks 609 actively recruiting clinical trials with at least one location in Florida. The total number of registered studies—including active but not currently enrolling trials—is 609. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Florida?
Florida hosts clinical trials across a broad range of medical conditions, including Heart Failure, Prostate Cancer, Alzheimer Disease, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Florida serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Florida?
To join a clinical trial in Florida, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Florida maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Florida

NCT06008795 Phase 2
Recruiting
BLOCK-SAH - PPF-Block for Post-SAH Headache
Condition
Subarachnoid Hemorrhage, Aneurysmal
Enrollment
195 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT06244992 Phase 1, Phase 2
Recruiting
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic ...
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
68 pts
Location
United States, China
Sponsor
Pyrotech Therapeutics, Inc.
View Trial →
NCT05756322 Phase 1, Phase 2
Recruiting
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Ac...
Condition
Relapsed or Resistant Acute Leukaemias
Enrollment
90 pts
Location
United States, Australia, China
Sponsor
Lin BioScience, Inc
View Trial →
NCT05316129 Phase 1
Recruiting
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ov...
Condition
Ovarian Cancer
Enrollment
10 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT06128551 Phase 1, Phase 2
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy i...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
534 pts
Location
United States, France, Germany
Sponsor
Revolution Medicines, Inc.
View Trial →
NCT06631105 N/A
Recruiting
Capability Assessment for Diet and Activity (CADA) Model for Diabetes
Condition
Diabetes
Enrollment
500 pts
Location
United States
Sponsor
University of Central Florida
View Trial →
NCT06388122 N/A
Recruiting
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
Condition
HER2-negative Breast Cancer
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT01775072 N/A
Recruiting
Genomic Profiling in Cancer Patients
Condition
Solid Tumors
Enrollment
200 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT05785754 Phase 1
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastat...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
320 pts
Location
United States, Australia, South Korea
Sponsor
DynamiCure Biotechnology
View Trial →
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
View Trial →
NCT07250802 Phase 3
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Condition
Plaque Psoriasis
Enrollment
110 pts
Location
United States, China, Germany
Sponsor
Takeda
View Trial →
NCT05172245 Phase 1
Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
46 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06741241 N/A
Recruiting
Effectiveness of an eHealth Intervention for Uptake of Cervical Cancer Screening...
Condition
Cervical Cancer Screening
Enrollment
170 pts
Location
United States
Sponsor
Florida A&M University
View Trial →
NCT07647354 N/A
Recruiting
Mako-MORE Registry
Condition
Arthropathy of Knee
Enrollment
950 pts
Location
United States
Sponsor
Stryker Orthopaedics
View Trial →
NCT04329494 Phase 1
Recruiting
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, U...
Condition
Clinical Stage IV Gastric Cancer AJCC v8
Enrollment
49 pts
Location
United States
Sponsor
City of Hope Medical Center
View Trial →
NCT06131840 Phase 1
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Condition
Colorectal Neoplasms
Enrollment
914 pts
Location
United States, Canada, China
Sponsor
Seagen, a wholly owned subsidi
View Trial →
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07743580 Phase 3
Recruiting
A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) ...
Condition
SARS-CoV-2
Enrollment
2,000 pts
Location
United States, Bulgaria, Japan
Sponsor
Shionogi
View Trial →
NCT06461897 Phase 3
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral U...
Condition
Atopic Dermatitis
Enrollment
675 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
View Trial →
NCT07711418 Phase 3
Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age W...
Condition
Moderate-to-Severe Atopic Dermatitis
Enrollment
510 pts
Location
United States
Sponsor
Nektar Therapeutics
View Trial →
NCT03850574 Phase 1, Phase 2
Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharma...
Condition
Leukemia, Myeloid, Acute
Enrollment
240 pts
Location
United States, Australia, Germany
Sponsor
Aptose Biosciences Inc.
View Trial →
NCT06827990 N/A
Recruiting
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissection...
Condition
Aortic Dissection
Enrollment
112 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT05549297 Phase 3
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced ...
Condition
Advanced Melanoma
Enrollment
540 pts
Location
United States, Australia, Austria
Sponsor
Immunocore Ltd
View Trial →
NCT03886662 Phase 1, Phase 2
Recruiting
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Sy...
Condition
Myelodysplastic Syndromes
Enrollment
47 pts
Location
United States
Sponsor
Lixte Biotechnology Holdings,
View Trial →
NCT05732103 Phase 1, Phase 2
Recruiting
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk...
Condition
Acute Myeloid Leukemia
Enrollment
225 pts
Location
United States
Sponsor
Chordia Therapeutics, Inc.
View Trial →
Page 6 of 25 — 609 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology